Firefreeze Worldwide, Inc., the manufacturer of Cold Fire, is pleased to announce the appointment of Equipro Ltd. as its exclusive global distributor (excluding the Americas), effective immediately.

The payer coverage changes suggests gradually increasing stringency around Ingrezza utilization, which may help explain Q4 weakness and the company’s disappointing FY25 guidance, the analyst ...

Competition to Austedo and Xenazine is also looming from Neurocrine Biosciences, whose VMAT2 drug Ingrezza (valbenazine) is already approved to treat tardive dyskinesia with a phase 3 readout in ...

After hours: March 12 at 6:24:06 PM EDT Loading Chart for NBIX ...